{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:00:50Z","timestamp":1791406850889,"version":"4.3.3"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autism spectrum disorders (ASD) are characterized by altered sociability, compromised communication and stereotyped\/repetitive behaviors, for which no specific treatments are currently available. Prenatal exposure to valproic acid (VPA) is a known, although still underestimated, environmental risk factor for ASD. Altered endocannabinoid activity has been observed in autistic patients, and endocannabinoids are known to modulate behavioral traits that are typically affected in ASD. On this basis, we tested the hypothesis that changes in the endocannabinoid tone contribute to the altered phenotype induced by prenatal VPA exposure in rats, with focus on behavioral features that resemble the core and associated symptoms of ASD. In the course of development, VPA-exposed rats showed early deficits in social communication and discrimination, compromised sociability and social play behavior, stereotypies and increased anxiety, thus providing preclinical proof of the long-lasting deleterious effects induced by prenatal VPA exposure. At the neurochemical level, VPA-exposed rats displayed altered phosphorylation of CB1 cannabinoid receptors in different brain areas, associated with changes in anandamide metabolism from infancy to adulthood. Interestingly, enhancing anandamide signaling through inhibition of its degradation rescued the behavioral deficits displayed by VPA-exposed rats at infancy, adolescence and adulthood. This study therefore shows that abnormalities in anandamide activity may underlie the deleterious impact of environmental risk factors on ASD-relevant behaviors and that the endocannabinoid system may represent a therapeutic target for the core and associated symptoms displayed by autistic patients.<\/jats:p>","DOI":"10.1038\/tp.2016.182","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T13:48:28Z","timestamp":1474984108000},"page":"e902-e902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid"],"prefix":"10.1038","volume":"6","author":[{"given":"M","family":"Servadio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Melancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Manduca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"di Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Schiavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Cartocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Pallottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Campolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ascenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"key":"BFtp2016182_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association Diagnostic and Statistic Manual of Mental Disorders: DMS-5, 5th edn. American Psychiatric Publishing: Arlington, VA, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"BFtp2016182_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"MC Lai","year":"2014","unstructured":"Lai MC, Lombardo MV, Baron-Cohen S . Autism. Lancet 2014; 383: 896\u2013910.","journal-title":"Lancet"},{"key":"BFtp2016182_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.rasd.2013.09.006","volume":"7","author":"A Mannion","year":"2013","unstructured":"Mannion A, Leader G . Comorbidity in autism spectrum disorder: a literature review. Research in Autism Spectrum Disorders 2013; 7: 1595\u20131616.","journal-title":"Research in Autism Spectrum Disorders"},{"key":"BFtp2016182_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1744-859X-11-16","volume":"11","author":"L Mazzone","year":"2012","unstructured":"Mazzone L, Ruta L, Reale L . Psychiatric comorbidities in Asperger syndrome and high functioning autism: diagnostic challenges. Ann Gen Psychiatry 2012; 11: 16.","journal-title":"Ann Gen Psychiatry"},{"key":"BFtp2016182_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10803-006-0215-x","volume":"37","author":"EI de Bruin","year":"2007","unstructured":"de Bruin EI, Ferdinand RF, Meester S, de Nijs PF, Verheij F . High rates of psychiatric co-morbidity in PDD-NOS. J Autism Dev Disord 2007; 37: 877\u2013886.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2016182_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/1744629507083585","volume":"11","author":"A Gillott","year":"2007","unstructured":"Gillott A, Standen PJ . Levels of anxiety and sources of stress in adults with autism. J Intellect Disabil 2007; 11: 359\u2013370.","journal-title":"J Intellect Disabil"},{"key":"BFtp2016182_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/CHI.0b013e318179964f","volume":"47","author":"E Simonoff","year":"2008","unstructured":"Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G . Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 2008; 47: 921\u2013929.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFtp2016182_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.biopsych.2014.11.001","volume":"77","author":"YS Kim","year":"2015","unstructured":"Kim YS, Leventhal BL . Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders. Biol Psychiatry 2015; 77: 66\u201374.","journal-title":"Biol Psychiatry"},{"key":"BFtp2016182_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fpsyt.2014.00053","volume":"5","author":"S Tordjman","year":"2014","unstructured":"Tordjman S, Somogyi E, Coulon N, Kermarrec S, Cohen D, Bronsard G et al. Gene x Environment interactions in autism spectrum disorders: role of epigenetic mechanisms. Front Psychiatry 2014; 5: 53.","journal-title":"Front Psychiatry"},{"key":"BFtp2016182_CR10","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.3402\/ehtj.v4i0.7111","volume":"4","author":"RR Dietert","year":"2011","unstructured":"Dietert RR, Dietert JM, Dewitt JC . Environmental risk factors for autism. Emerg Health Threats J 2011; 4: 7111.","journal-title":"Emerg Health Threats J"},{"key":"BFtp2016182_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1469-8749.1997.tb07500.x","volume":"39","author":"PG Williams","year":"1997","unstructured":"Williams PG, Hersh JH . A male with fetal valproate syndrome and autism. Dev Med Child Neurol 1997; 39: 632\u2013634.","journal-title":"Dev Med Child Neurol"},{"key":"BFtp2016182_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","volume":"43","author":"G Williams","year":"2001","unstructured":"Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH . Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001; 43: 202\u2013206.","journal-title":"Dev Med Child Neurol"},{"key":"BFtp2016182_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2","volume":"370","author":"PM Rodier","year":"1996","unstructured":"Rodier PM, Ingram JL, Tisdale B, Nelson S, Romano J . Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 1996; 370: 247\u2013261.","journal-title":"J Comp Neurol"},{"key":"BFtp2016182_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","volume":"36","author":"GC Wagner","year":"2006","unstructured":"Wagner GC, Reuhl KR, Cheh M, McRae P, Halladay AK . A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J Autism Dev Disord 2006; 36: 779\u2013793.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2016182_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.npp.1300518","volume":"30","author":"T Schneider","year":"2005","unstructured":"Schneider T, Przewlocki R . Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005; 30: 80\u201389.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2016182_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/FBP.0000000000000163","volume":"26","author":"M Servadio","year":"2015","unstructured":"Servadio M, Vanderschuren LJ, Trezza V . Modeling autism-relevant behavioral phenotypes in rats and mice: do 'autistic' rodents exist? Behav Pharmacol 2015; 26: 522\u2013540.","journal-title":"Behav Pharmacol"},{"key":"BFtp2016182_CR17","unstructured":"Inspection g\u00e9n\u00e9rale des affaires sociales (IGAS). Enqu\u00eate relative aux sp\u00e9cialit\u00e9s pharmaceutiques contenant du valproate de sodium. IGAS, France 2016."},{"key":"BFtp2016182_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","volume":"83","author":"TF Freund","year":"2003","unstructured":"Freund TF, Katona I, Piomelli D . Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003; 83: 1017\u20131066.","journal-title":"Physiol Rev"},{"key":"BFtp2016182_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D . The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003; 4: 873\u2013884.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp2016182_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.tips.2006.01.010","volume":"27","author":"V Di Marzo","year":"2006","unstructured":"Di Marzo V . A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists. Trends Pharmacol Sci 2006; 27: 134\u2013140.","journal-title":"Trends Pharmacol Sci"},{"key":"BFtp2016182_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G . The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006; 58: 389\u2013462.","journal-title":"Pharmacol Rev"},{"key":"BFtp2016182_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF03349186","volume":"29","author":"G Marsicano","year":"2006","unstructured":"Marsicano G, Lutz B . Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest 2006; 29: 27\u201346.","journal-title":"J Endocrinol Invest"},{"key":"BFtp2016182_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0269881111408459","volume":"26","author":"EM Marco","year":"2012","unstructured":"Marco EM, Laviola G . The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives. J Psychopharmacol 2012; 26: 150\u2013163.","journal-title":"J Psychopharmacol"},{"key":"BFtp2016182_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuroscience.2011.07.052","volume":"204","author":"RJ McLaughlin","year":"2012","unstructured":"McLaughlin RJ, Gobbi G . Cannabinoids and emotionality: a neuroanatomical perspective. Neuroscience 2012; 204: 134\u2013144.","journal-title":"Neuroscience"},{"key":"BFtp2016182_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnbeh.2012.00002","volume":"6","author":"V Trezza","year":"2012","unstructured":"Trezza V, Campolongo P, Manduca A, Morena M, Palmery M, Vanderschuren LJ et al. Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. Front Behav Neurosci 2012; 6: 2.","journal-title":"Front Behav Neurosci"},{"key":"BFtp2016182_CR26","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1111\/j.1460-9568.2006.04697.x","volume":"23","author":"B Chakrabarti","year":"2006","unstructured":"Chakrabarti B, Kent L, Suckling J, Bullmore E, Baron-Cohen S . Variations in the human cannabinoid receptor (CNR1) gene modulate striatal responses to happy faces. Eur J Neurosci 2006; 23: 1944\u20131948.","journal-title":"Eur J Neurosci"},{"key":"BFtp2016182_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2040-2392-2-10","volume":"2","author":"B Chakrabarti","year":"2011","unstructured":"Chakrabarti B, Baron-Cohen S . Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces. Mol Autism 2011; 2: 10.","journal-title":"Mol Autism"},{"key":"BFtp2016182_CR28","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/npp.2010.19","volume":"35","author":"M Maccarrone","year":"2010","unstructured":"Maccarrone M, Rossi S, Bari M, De Chiara V, Rapino C, Musella A et al. Abnormal mGlu 5 receptor\/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology 2010; 35: 1500\u20131509.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2016182_CR29","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/ncomms2045","volume":"3","author":"KM Jung","year":"2012","unstructured":"Jung KM, Sepers M, Henstridge CM, Lassalle O, Neuhofer D, Martin H et al. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat Commun 2012; 3: 1080.","journal-title":"Nat Commun"},{"key":"BFtp2016182_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nm.3127","volume":"19","author":"A Busquets-Garcia","year":"2013","unstructured":"Busquets-Garcia A, Gomis-Gonzalez M, Guegan T, Agustin-Pavon C, Pastor A, Mato S et al. Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med 2013; 19: 603\u2013607.","journal-title":"Nat Med"},{"key":"BFtp2016182_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","volume":"8","author":"QR Liu","year":"2009","unstructured":"Liu QR, Pan CH, Hishimoto A, Li CY, Xi ZX, Llorente-Berzal A et al. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav 2009; 8: 519\u2013530.","journal-title":"Genes Brain Behav"},{"key":"BFtp2016182_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbr.2013.04.043","volume":"249","author":"DM Kerr","year":"2013","unstructured":"Kerr DM, Downey L, Conboy M, Finn DP, Roche M . Alterations in the endocannabinoid system in the rat valproic acid model of autism. Behav Brain Res 2013; 249: 124\u2013132.","journal-title":"Behav Brain Res"},{"key":"BFtp2016182_CR33","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1007\/s10803-013-1824-9","volume":"43","author":"D Siniscalco","year":"2013","unstructured":"Siniscalco D, Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F et al. Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. J Autism Dev Disord 2013; 43: 2686\u20132695.","journal-title":"J Autism Dev Disord"},{"key":"BFtp2016182_CR34","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.euroneuro.2014.05.009","volume":"24","author":"A Manduca","year":"2014","unstructured":"Manduca A, Servadio M, Campolongo P, Palmery M, Trabace L, Vanderschuren LJ et al. Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats. Eur Neuropsychopharmacol 2014; 24: 1337\u20131348.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2016182_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nm803","volume":"9","author":"S Kathuria","year":"2003","unstructured":"Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003; 9: 76\u201381.","journal-title":"Nat Med"},{"key":"BFtp2016182_CR36","doi-asserted-by":"publisher","first-page":"14899","DOI":"10.1523\/JNEUROSCI.0114-12.2012","volume":"32","author":"V Trezza","year":"2012","unstructured":"Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ et al. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. J Neurosci 2012; 32: 14899\u201314908.","journal-title":"J Neurosci"},{"key":"BFtp2016182_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00213-007-1025-3","volume":"197","author":"V Trezza","year":"2008","unstructured":"Trezza V, Vanderschuren LJ . Bidirectional cannabinoid modulation of social behavior in adolescent rats. Psychopharmacology (Berl) 2008; 197: 217\u2013227.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp2016182_CR38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1124\/jpet.106.101287","volume":"318","author":"S Patel","year":"2006","unstructured":"Patel S, Hillard CJ . Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 2006; 318: 304\u2013311.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp2016182_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuropharm.2007.07.005","volume":"54","author":"FA Moreira","year":"2008","unstructured":"Moreira FA, Kaiser N, Monory K, Lutz B . Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 2008; 54: 141\u2013150.","journal-title":"Neuropharmacology"},{"key":"BFtp2016182_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/can.2015.0008","volume":"1.1","author":"D Wei","year":"2016","unstructured":"Wei D, Dinh D, Lee D, Li D, Anguren A, Moreno-Sanz G et al. Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment. Cannabis Cannabinoid Res 2016; 1.1: 81\u201389.","journal-title":"Cannabis Cannabinoid Res"},{"key":"BFtp2016182_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/sj.npp.1301453","volume":"33","author":"K Markram","year":"2008","unstructured":"Markram K, Rinaldi T, La Mendola D, Sandi C, Markram H . Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2008; 33: 901\u2013912.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2016182_CR42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.euroneuro.2008.03.001","volume":"18","author":"V Trezza","year":"2008","unstructured":"Trezza V, Vanderschuren LJ . Cannabinoid and opioid modulation of social play behavior in adolescent rats: differential behavioral mechanisms. Eur Neuropsychopharmacol 2008; 18: 519\u2013530.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2016182_CR43","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/npp.2013.284","volume":"39","author":"M Segatto","year":"2014","unstructured":"Segatto M, Manduca A, Lecis C, Rosso P, Jozwiak A, Swiezewska E et al. Simvastatin treatment highlights a new role for the isoprenoid\/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats. Neuropsychopharmacology 2014; 39: 841\u2013854.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2016182_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S","volume":"34","author":"SM Brudzynski","year":"1999","unstructured":"Brudzynski SM, Kehoe P, Callahan M . Sonographic structure of isolation-induced ultrasonic calls of rat pups. Dev Psychobiol 1999; 34: 195\u2013204.","journal-title":"Dev Psychobiol"},{"key":"BFtp2016182_CR45","doi-asserted-by":"publisher","first-page":"e3067","DOI":"10.1371\/journal.pone.0003067","volume":"3","author":"ML Scattoni","year":"2008","unstructured":"Scattoni ML, Gandhy SU, Ricceri L, Crawley JN . Unusual repertoire of vocalizations in the BTBR T+tf\/J mouse model of autism. PLoS One 2008; 3: e3067.","journal-title":"PLoS One"},{"key":"BFtp2016182_CR46","doi-asserted-by":"publisher","first-page":"e84948","DOI":"10.1371\/journal.pone.0084948","volume":"9","author":"KK Gulia","year":"2014","unstructured":"Gulia KK, Patel N, Radhakrishnan A, Mohan Kumar V . Reduction in ultrasonic vocalizations in pups born to rapid eye movement sleep restricted mothers in rat model. PLoS One 2014; 9: e84948.","journal-title":"PLoS One"},{"key":"BFtp2016182_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbr.2006.07.030","volume":"176","author":"SS Moy","year":"2007","unstructured":"Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007; 176: 4\u201320.","journal-title":"Behav Brain Res"},{"key":"BFtp2016182_CR48","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1124\/jpet.108.141069","volume":"328","author":"V Trezza","year":"2009","unstructured":"Trezza V, Vanderschuren LJ . Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats. J Pharmacol Exp Ther 2009; 328: 343\u2013350.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp2016182_CR49","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1038\/npp.2008.10","volume":"33","author":"LJ Vanderschuren","year":"2008","unstructured":"Vanderschuren LJ, Trezza V, Griffioen-Roose S, Schiepers OJ, Van Leeuwen N, De Vries TJ et al. Methylphenidate disrupts social play behavior in adolescent rats. Neuropsychopharmacology 2008; 33: 2946\u20132956.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2016182_CR50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0028-3908(89)90038-5","volume":"28","author":"RJ Niesink","year":"1989","unstructured":"Niesink RJ, Van Ree JM . Involvement of opioid and dopaminergic systems in isolation-induced pinning and social grooming of young rats. Neuropharmacology 1989; 28: 411\u2013418.","journal-title":"Neuropharmacology"},{"key":"BFtp2016182_CR51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02245191","volume":"117","author":"LJ Vanderschuren","year":"1995","unstructured":"Vanderschuren LJ, Niesink RJ, Spruijt BM, Van Ree JM . Effects of morphine on different aspects of social play in juvenile rats. Psychopharmacology (Berl) 1995; 117: 225\u2013231.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp2016182_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/1098-2337(1987)13:4<227::AID-AB2480130406>3.0.CO;2-C","volume":"13","author":"SM Pellis","year":"1987","unstructured":"Pellis SM, Pellis VC . Play-fighting differs from serious fighting in both target of attack and tactics of fighting in the laboratory rat Rattus norvegicus. Aggress Behav 1987; 13: 227\u2013242.","journal-title":"Aggress Behav"},{"key":"BFtp2016182_CR53","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.euroneuro.2015.04.005","volume":"25","author":"A Manduca","year":"2015","unstructured":"Manduca A, Morena M, Campolongo P, Servadio M, Palmery M, Trabace L et al. Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats. Eur Neuropsychopharmacol 2015; 25: 1362\u20131374.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2016182_CR54","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1471-4159.2008.05336.x","volume":"106","author":"TL Daigle","year":"2008","unstructured":"Daigle TL, Kwok ML, Mackie K . Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism. J Neurochem 2008; 106: 70\u201382.","journal-title":"J Neurochem"},{"key":"BFtp2016182_CR55","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1523\/JNEUROSCI.18-08-02834.1998","volume":"18","author":"DE Garcia","year":"1998","unstructured":"Garcia DE, Brown S, Hille B, Mackie K . Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci 1998; 18: 2834\u20132841.","journal-title":"J Neurosci"},{"key":"BFtp2016182_CR56","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.biopsych.2010.09.031","volume":"68","author":"MJ Gandal","year":"2010","unstructured":"Gandal MJ, Edgar JC, Ehrlichman RS, Mehta M, Roberts TP, Siegel SJ . Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism. Biol Psychiatry 2010; 68: 1100\u20131106.","journal-title":"Biol Psychiatry"},{"key":"BFtp2016182_CR57","doi-asserted-by":"publisher","first-page":"e37313","DOI":"10.1371\/journal.pone.0037313","volume":"7","author":"AC Felix-Ortiz","year":"2012","unstructured":"Felix-Ortiz AC, Febo M . Gestational valproate alters BOLD activation in response to complex social and primary sensory stimuli. PLoS One 2012; 7: e37313.","journal-title":"PLoS One"},{"key":"BFtp2016182_CR58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bbr.2013.09.049","volume":"257","author":"RX Moldrich","year":"2013","unstructured":"Moldrich RX, Leanage G, She D, Dolan-Evans E, Nelson M, Reza N et al. Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. Behav Brain Res 2013; 257: 253\u2013264.","journal-title":"Behav Brain Res"},{"key":"BFtp2016182_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1247190","volume":"343","author":"R Tyzio","year":"2014","unstructured":"Tyzio R, Nardou R, Ferrari DC, Tsintsadze T, Shahrokhi A, Eftekhari S et al. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 2014; 343: 675\u2013679.","journal-title":"Science"},{"key":"BFtp2016182_CR60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00441-013-1607-9","volume":"354","author":"M Wohr","year":"2013","unstructured":"Wohr M, Schwarting RK . Affective communication in rodents: ultrasonic vocalizations as a tool for research on emotion and motivation. Cell Tissue Res 2013; 354: 81\u201397.","journal-title":"Cell Tissue Res"},{"key":"BFtp2016182_CR61","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.neuroscience.2010.06.069","volume":"170","author":"FI Roullet","year":"2010","unstructured":"Roullet FI, Wollaston L, Decatanzaro D, Foster JA . Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. Neuroscience 2010; 170: 514\u2013522.","journal-title":"Neuroscience"},{"key":"BFtp2016182_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fnbeh.2013.00088","volume":"7","author":"MR Favre","year":"2013","unstructured":"Favre MR, Barkat TR, Lamendola D, Khazen G, Markram H, Markram K . General developmental health in the VPA-rat model of autism. Front Behav Neurosci 2013; 7: 88.","journal-title":"Front Behav Neurosci"},{"key":"BFtp2016182_CR63","doi-asserted-by":"publisher","first-page":"e976123","DOI":"10.4161\/23273747.2014.976123","volume":"2","author":"S Degroote","year":"2015","unstructured":"Degroote S, Hunting D, Sebire G, Takser L . Autistic-like traits in Lewis rats exposed perinatally to a mixture of common endocrine disruptors. Endocr Disruptors 2015; 2: e976123.","journal-title":"Endocr Disruptors"},{"key":"BFtp2016182_CR64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/dev.20130","volume":"48","author":"AI Melo","year":"2006","unstructured":"Melo AI, Lovic V, Gonzalez A, Madden M, Sinopoli K, Fleming AS . Maternal and littermate deprivation disrupts maternal behavior and social-learning of food preference in adulthood: tactile stimulation, nest odor, and social rearing prevent these effects. Dev Psychobiol 2006; 48: 209\u2013219.","journal-title":"Dev Psychobiol"},{"key":"BFtp2016182_CR65","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/(SICI)1098-2302(199605)29:4<353::AID-DEV4>3.0.CO;2-P","volume":"29","author":"LM Terry","year":"1996","unstructured":"Terry LM, Johanson IB . Effects of altered olfactory experiences on the development of infant rats' responses to odors. Dev Psychobiol 1996; 29: 353\u2013377.","journal-title":"Dev Psychobiol"},{"key":"BFtp2016182_CR66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.npp.1300767","volume":"31","author":"T Schneider","year":"2006","unstructured":"Schneider T, Turczak J, Przewlocki R . Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 2006; 31: 36\u201346.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2016182_CR67","doi-asserted-by":"publisher","first-page":"e104927","DOI":"10.1371\/journal.pone.0104927","volume":"9","author":"JW Kim","year":"2014","unstructured":"Kim JW, Seung H, Kwon KJ, Ko MJ, Lee EJ, Oh HA et al. Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism. PLoS One 2014; 9: e104927.","journal-title":"PLoS One"},{"key":"BFtp2016182_CR68","doi-asserted-by":"publisher","first-page":"e0116363","DOI":"10.1371\/journal.pone.0116363","volume":"10","author":"D Baronio","year":"2015","unstructured":"Baronio D, Castro K, Gonchoroski T, de Melo GM, Nunes GD, Bambini-Junior V et al. Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid. PLoS One 2015; 10: e0116363.","journal-title":"PLoS One"},{"key":"BFtp2016182_CR69","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/FBP.0000000000000169","volume":"26","author":"S Raza","year":"2015","unstructured":"Raza S, Himmler BT, Himmler SM, Harker A, Kolb B, Pellis SM et al. Effects of prenatal exposure to valproic acid on the development of juvenile-typical social play in rats. Behav Pharmacol 2015; 26: 707\u2013719.","journal-title":"Behav Pharmacol"},{"key":"BFtp2016182_CR70","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1523\/JNEUROSCI.5603-07.2008","volume":"28","author":"KL Phan","year":"2008","unstructured":"Phan KL, Angstadt M, Golden J, Onyewuenyi I, Popovska A, de Wit H . Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci 2008; 28: 2313\u20132319.","journal-title":"J Neurosci"},{"key":"BFtp2016182_CR71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/aur.122","volume":"3","author":"AA Scott-Van Zeeland","year":"2010","unstructured":"Scott-Van Zeeland AA, Dapretto M, Ghahremani DG, Poldrack RA, Bookheimer SY . Reward processing in autism. Autism Res 2010; 3: 53\u201367.","journal-title":"Autism Res"},{"key":"BFtp2016182_CR72","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0149-7634(00)00011-7","volume":"24","author":"S Baron-Cohen","year":"2000","unstructured":"Baron-Cohen S, Ring HA, Bullmore ET, Wheelwright S, Ashwin C, Williams SC . The amygdala theory of autism. Neurosci Biobehav Rev 2000; 24: 355\u2013364.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtp2016182_CR73","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1038\/sj.npp.1301061","volume":"31","author":"M Bortolato","year":"2006","unstructured":"Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V et al. Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 2006; 31: 2652\u20132659.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2016182_CR74","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbr.2011.01.044","volume":"220","author":"EM Marco","year":"2011","unstructured":"Marco EM, Rapino C, Caprioli A, Borsini F, Maccarrone M, Laviola G . Social encounter with a novel partner in adolescent rats: activation of the central endocannabinoid system. Behav Brain Res 2011; 220: 140\u2013145.","journal-title":"Behav Brain Res"},{"key":"BFtp2016182_CR75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuropharm.2010.09.003","volume":"60","author":"N Realini","year":"2011","unstructured":"Realini N, Vigano D, Guidali C, Zamberletti E, Rubino T, Parolaro D . Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology 2011; 60: 235\u2013243.","journal-title":"Neuropharmacology"},{"key":"BFtp2016182_CR76","doi-asserted-by":"publisher","first-page":"e26077","DOI":"10.1371\/journal.pone.0026077","volume":"6","author":"MV Mehta","year":"2011","unstructured":"Mehta MV, Gandal MJ, Siegel SJ . mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLoS One 2011; 6: e26077.","journal-title":"PLoS One"},{"key":"BFtp2016182_CR77","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fphar.2012.00110","volume":"3","author":"T Morera-Herreras","year":"2012","unstructured":"Morera-Herreras T, Miguelez C, Aristieta A, Ruiz-Ortega JA, Ugedo L . Endocannabinoid modulation of dopaminergic motor circuits. Front Pharmacol 2012; 3: 110.","journal-title":"Front Pharmacol"},{"key":"BFtp2016182_CR78","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/sj.npp.1301558","volume":"33","author":"AB Martin","year":"2008","unstructured":"Martin AB, Fernandez-Espejo E, Ferrer B, Gorriti MA, Bilbao A, Navarro M et al. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 2008; 33: 1667\u20131679.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2016182_CR79","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1523\/JNEUROSCI.20-09-03401.2000","volume":"20","author":"M Beltramo","year":"2000","unstructured":"Beltramo M, de Fonseca FR, Navarro M, Calignano A, Gorriti MA, Grammatikopoulos G et al. Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J Neurosci 2000; 20: 3401\u20133407.","journal-title":"J Neurosci"},{"key":"BFtp2016182_CR80","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1017\/S1461145712000569","volume":"16","author":"MJ Luque-Rojas","year":"2013","unstructured":"Luque-Rojas MJ, Galeano P, Suarez J, Araos P, Santin LJ, de Fonseca FR et al. Hyperactivity induced by the dopamine D2\/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice. Int J Neuropsychopharmacol 2013; 16: 661\u2013676.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp2016182_CR81","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejphar.2007.01.009","volume":"559","author":"B Ferrer","year":"2007","unstructured":"Ferrer B, Gorriti MA, Palomino A, Gornemann I, de Diego Y, Bermudez-Silva FJ et al. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies. Eur J Pharmacol 2007; 559: 180\u2013183.","journal-title":"Eur J Pharmacol"},{"key":"BFtp2016182_CR82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2015.10.007","volume":"91","author":"H Kumar","year":"2015","unstructured":"Kumar H, Sharma BM, Sharma B . Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder. Neurochem Int 2015; 91: 34\u201345.","journal-title":"Neurochem Int"},{"key":"BFtp2016182_CR83","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","volume":"33","author":"T Schneider","year":"2008","unstructured":"Schneider T, Roman A, Basta-Kaim A, Kubera M, Budziszewska B, Schneider K et al. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 2008; 33: 728\u2013740.","journal-title":"Psychoneuroendocrinology"},{"key":"BFtp2016182_CR84","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00213-006-0689-4","volume":"192","author":"PS Naidu","year":"2007","unstructured":"Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH . Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology (Berl) 2007; 192: 61\u201370.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp2016182_CR85","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00213-009-1494-7","volume":"204","author":"J Haller","year":"2009","unstructured":"Haller J, Barna I, Barsvari B, Gyimesi Pelczer K, Yasar S, Panlilio LV et al. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology (Berl) 2009; 204: 607\u2013616.","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2016182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016182","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2016182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T16:32:29Z","timestamp":1718814749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2016182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":85,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"alternative-id":["BFtp2016182"],"URL":"https:\/\/doi.org\/10.1038\/tp.2016.182","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]},"assertion":[{"value":"2 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}